Ísrael - hebreska - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - medroxyprogesterone acetate - טבליה - medroxyprogesterone acetate 5 mg - medroxyprogesterone - medroxyprogesterone - in cases requiring progesterone supplement.

Ísrael - hebreska - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - medroxyprogesterone acetate - תרחיף להזרקה - medroxyprogesterone acetate 104 mg / 0.65 ml - medroxyprogesterone - medroxyprogesterone - * sayana is indicated for long-term female contraception. each subcutaneous injection prevents ovulation and provides contraception for at least 13 weeks (+/- 1 week). however, it should be taken into consideration that the return to fertility (ovulation) may be delayed for up to one year .since loss of bone mineral density may occur in females of all ages who use sayana long-term, a risk/benefit assessment, which also takes into consideration the decrease in bone mineral density that occurs during pregnancy and/or lactation, should be considered.* use in adolescents (12-18 years)in adolescents, use of sayana is only indicated when other contraceptive methods are considered unsuitable or unacceptable, due to unknown long-term effects of bone loss associated with sayana during the critical period of bone accretion.sayana has not been studied in women under the age of 18 years but data is available for intramuscular medroxyprogesterone acetate in this population.

Ísrael - hebreska - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - ethinylestradiol; gestodene - טבליה - gestodene 0.075 mg; ethinylestradiol 0.030 mg - ethinylestradiol - ethinylestradiol - contraception.

Ísrael - hebreska - Ministry of Health

pfizer pharmaceuticals israel ltd - medroxyprogesterone acetate 100 mg - tablets - medroxyprogesterone - progestogen indicated for the treatment of certain hormone dependent neoplasms.

Ísrael - hebreska - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - tolterodine l-tartrate - קפסולות בשחרור איטי - tolterodine l-tartrate 4 mg - tolterodine - tolterodine - for the treatment of patients with an overactive bladder with symptoms of urinary frequency, urgency or urge incontinence.

Ísrael - hebreska - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - tolterodine l-tartrate - קפסולות בשחרור איטי - tolterodine l-tartrate 2 mg - tolterodine - tolterodine - for the treatment of patients with an overactive bladder with symptoms of urinary frequency, urgency or urge incontinence.

Ísrael - hebreska - Ministry of Health

pfizer pharmaceuticals israel ltd - fesoterodine fumarate - טבליות עם שחרור מושהה - fesoterodine fumarate 4 mg - fesoterodine - fesoterodine - treatment of the symptoms (increased urinary frequency and/or urgency and/or urgency incontinence) that may occur in patients with overactive bladder syndrome.

Ísrael - hebreska - Ministry of Health

pfizer pharmaceuticals israel ltd - fesoterodine fumarate - טבליות עם שחרור מושהה - fesoterodine fumarate 8 mg - fesoterodine - fesoterodine - treatment of the symptoms (increased urinary frequency and/or urgency and/or urgency incontinence) that may occur in patients with overactive bladder syndrome.

Ísrael - hebreska - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - alprostadil - אבקה להכנת תמיסה לזריקה - alprostadil 20 mcg/vial - alprostadil - alprostadil - treatment of erectile dysfunction. useful adjunct to other diagnostic tests in the diagnosis of erectile dysfunction.

Ísrael - hebreska - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - alprostadil - אבקה להכנת תמיסה לזריקה - alprostadil 20 mcg/vial - alprostadil - alprostadil - treatment of erectile dysfunction. useful adjunct to other diagnostic tests in the diagnosis of erectile dysfunction.